SWX:NOVNPharmaceuticals
Novartis (SWX:NOVN) Says AI Could Speed Drug Discovery And Development
Novartis CEO has outlined plans to scale the use of artificial intelligence across the company’s research and development operations.
The focus is on using AI to shorten drug discovery timelines and support better clinical decision making.
This shift points to a potential long term change in how Novartis approaches its core business of developing new medicines.
For investors watching SWX:NOVN, the update on AI comes after a period of strong share price performance, with the stock at...